Evidence for Proteotoxicity in β Cells in Type 2 Diabetes: Toxic Islet Amyloid Polypeptide Oligomers Form Intracellularly in the Secretory Pathway
- 28 February 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 176 (2), 861-869
- https://doi.org/10.2353/ajpath.2010.090532
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Amyloidogenic Propensities and Conformational Properties of ProIAPP and IAPP in the Presence of Lipid Bilayer MembranesJournal of Molecular Biology, 2009
- Desmin-related cardiomyopathy in transgenic mice: A cardiac amyloidosisProceedings of the National Academy of Sciences of the United States of America, 2004
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Cell death regulation by the Bcl‐2 protein family in the mitochondriaJournal of Cellular Physiology, 2003
- β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 DiabetesDiabetes, 2003
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Dense core secretory vesicles revealed as a dynamic Ca2+store in neuroendocrine cells with a vesicle-associated membrane protein aequorin chimaeraThe Journal of cell biology, 2001
- Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic HumansDiabetes, 1990
- Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between speciesFEBS Letters, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989